N-((1R,2S,5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO[1,5-A][1,3,5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE, A DUAL MODULATOR OF CHEMOKINE RECEPTOR ACTIVITY, CRYSTALLINE FORMS AND PROCESSES

(19)

(11)

EP 2 488 523 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	16.04.2014 Bulletin 2014/16

(45)	Mention of the grant of the patent:
	20.11.2013 Bulletin 2013/47

(21)	Application number: 10768153.8

(22)	Date of filing: 12.10.2010

(51)

International Patent Classification (IPC):

C07D 487/04^(2006.01)
A61P 37/00^(2006.01)

A61K 31/53^(2006.01)

(86)	International application number:
	PCT/US2010/052288

(87)	International publication number:
	WO 2011/046916 (21.04.2011 Gazette 2011/16)

(54)

N-((1R,2S,5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO[1,5-A][1,3,5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE, A DUAL MODULATOR OF CHEMOKINE RECEPTOR ACTIVITY, CRYSTALLINE FORMS AND PROCESSES

N-((1R, 2S, 5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO [1, 5-A][1, 3, 5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMID, ALS ZWEIFACH AKTIVE CHEMOKINE REZEPTOR MODULATOR, KRISTALLINE FORMEN UND VERFAHREN

N-((1R, 2S, 5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO [1, 5-A][1, 3, 5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE, EN TANT QUE DOUBLES MODULATEUR DE RECEPTEUR CHEMOKINE, FORMES CRISTALLINES ET PROCEDES

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

13.10.2009 US 250978 P

(43)	Date of publication of application:
	22.08.2012 Bulletin 2012/34

(60)	Divisional application:
	13180657.2 / 2664620

(73)	Proprietor: Bristol-Myers Squibb Company
	Princeton, NJ 08543-4000 (US)

(72)	Inventors:
	CARTER, Percy H. New Jersey 08543 (US) CHERNEY, Robert J. New Jersey 08543 (US) ROSSO, Victor W. New Jersey 08903 (US) LI, Jun New Jersey 08903 (US)

(74)	Representative: Beacham, Annabel Rose
	Dehns St Bride's House 10 Salisbury Square London EC4Y 8JD London EC4Y 8JD (GB)

(56)

References cited: :

WO-A1-02/50079
WO-A2-2008/014381

WO-A2-2008/014360
US-A1- 2005 054 627

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).